This High-Growth Small Cap Is On The Front Lines Of Developing Therapies For Potential Bio Attacks – And It’s Trading At A Discount
With the recent sell-off in biotech stocks, the author of today’s article advises that “this is the perfect opportunity to buy into high-growth biotech stocks… Read More »This High-Growth Small Cap Is On The Front Lines Of Developing Therapies For Potential Bio Attacks – And It’s Trading At A Discount
The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
“While volatility still permeates the broad market, one segment has seen a fairly consistent upward trend through the bulk of the year. That segment is,… Read More »The Tailwinds Behind Biotech – And How Both Traders And Investors Can Profit With ETFs
You’ve identified and bought a stock that you believe is undervalued. Now, the critical question becomes how long do you wait for that undervalued stock… Read More »Waiting For Rewards From Undervalued Stocks
When predicting where the stock market will go, the author of today’s article acknowledges that “It’s easy to see what’s happening now, compare that with… Read More »Investing When Expecting The Unexpected
“You’re looking at a group of profitable enterprises with staying power,” states the author of today’s article in regards to the eleven dividend growth stocks… Read More »Dividend Growers For Further Consideration
Based on one historical template, the trend for gold stocks is “table-pounding bullish”, notes today’s article. That historical template? The recovery from a “mega bear… Read More »The Historical Template That Is “Table-Pounding Bullish” For Gold Stocks